Allergy Therapeutics
AGY.L
#7660
Rank
C$0.64 B
Marketcap
C$0.10
Share price
-0.02%
Change (1 day)
-33.02%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2025: -C$75.97 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are C$75.57 Million. In 2025 the company made an earning of -C$75.97 Million a decrease over its 2024 earnings that were of -C$69.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025-C$75.97 Million8.65%
2024-C$69.93 Million-6.69%
2023-C$74.94 Million244.94%
2022-C$21.73 Million-404.35%
2021C$7.13 M-49.42%
2020C$14.11 M83.48%
2019C$7.69 M-159.83%
2018-C$12.86 Million255.48%
2017-C$3.62 Million-84.06%
2016-C$22.7 Million-1667.33%
2015C$1.44 M-44.68%
2014C$2.61 M130.59%
2013C$1.13 M-19.89%
2012C$1.41 M-127.05%
2011-C$5.24 Million2009.96%
2010-C$0.25 Million-99.07%
2009-C$26.61 Million-53.23%
2008-C$56.88 Million-21.86%
2007-C$72.79 Million356.94%
2006-C$15.93 Million230.75%
2005-C$4.82 Million-217.9%
2004C$4.08 M-58.79%
2003C$9.91 M-196.03%
2002-C$10.33 Million